TRANSMEDICS GROUP INC

TRANSMEDICS GROUP INC

TransMedics Group Inc (TMDX) develops organ preservation and transport systems designed to improve transplant outcomes and expand donor organ utilisation. Its flagship Organ Care System (OCS) platforms keep hearts, lungs and livers functioning outside the body by perfusing them with warm, oxygenated blood, enabling longer preservation, active assessment and potential use of marginal donors. The company generates revenue from capital equipment sales and recurring disposables used for each transplant, supported by training and clinical data to drive adoption. Growth depends on clinical acceptance, reimbursement, regulatory approvals and transplant volumes; the business can offer attractive recurring revenue if hospitals scale use. Key risks include regulatory or clinical setbacks, reimbursement uncertainty, hospital purchasing cycles, competition and historical operating losses. Market cap is approximately US$4.1bn (provided). This is general educational information, not personal financial advice; values can fall as well as rise.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts suggest buying TransMedics Group stock with a target price of $146.31, indicating potential growth.

Above Average

Financial Health

TransMedics Group is showing strong revenue and cash flow, indicating healthy business performance.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring TMDX

Wearable Tech IP Wars: What Investors Should Know

Wearable Tech IP Wars: What Investors Should Know

Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.

Published: August 21, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Recurring Consumables Demand

Each transplant uses single‑use disposables, offering recurring revenue potential as procedures scale, though volumes rely on adoption and reimbursement.

⚑

Clinical Outcomes Focus

OCS lets clinicians assess organs outside the body, which may increase usable donors; clinical evidence and trial results will influence uptake.

🌍

Addressing Organ Shortage

The global transplant market is substantial and the technology targets unmet need, but growth depends on hospital budgets, regulation and payer support.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

A

Agilent Technologies Inc.

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.

ALGN

Align Technology Inc.

Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.

Frequently asked questions